Search

Your search keyword '"ANDERSON, JENNIFER"' showing total 11 results
Start Over Author "ANDERSON, JENNIFER" Journal blood
11 results on '"ANDERSON, JENNIFER"'

3. A Prospective Study of IV Pentamidine for Pneumocystis Jirovecii Pneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy

Author

Anderson, Jennifer, primary, Wirth, Scott, additional, Patel, Pritesh R., additional, Quigley, John G., additional, Oh, Annie L., additional, Mactal-Haaf, Christina, additional, Khan, Irum, additional, Rondelli, Damiano, additional, and Sweiss, Karen, additional

Published
2016
Full Text
View/download PDF

5. Consolidation with Autologous Hematopoietic Cell Transplant in First Remission Improves Overall Survival in Younger Patients with Mantle Cell Lymphoma in the Rituximab Era

Author

Gerson, James Nathan, Barta, Stefan Klaus, Villa, Diego, Gerrie, Alina S, Li, Shaoying, Medeiros, Jeffrey, Wang, Michael, Hill, Brian T., Sawalha, Yazeed, Hernandez-Ilizaliturri, Francisco J., Kothari, Shalin, Vose, Julie M, Fenske, Timothy S., Narayana Rao, Swapna, Maddocks, Kami J., Bond, David A, Lansigan, Frederick, Burns, Timothy, Donovan, Alexandra M, Mehta, Amitkumar, Reddy, Nishitha, Landsburg, Daniel J., Glenn, Martha, Inwards, David James, Ristow, Kay, Karmali, Reem, Kaplan, Jason, Umyarova, Elvira, Pulluri, Bhargavi, Amengual, Jennifer E, Lue, Jennifer Kimberly, Caimi, Paolo, Cohen, Jonathon B, Calzada, Oscar, Handorf, Elizabeth, Anderson, Jennifer Kelly, Chapani, Parv, Bachanova, Veronika, Rajguru, Saurabh, Churnetski, Michael C, Diefenbach, Catherine, Bast, Martin, and Kovach, Alexandra E.

Published
2017
Full Text
View/download PDF

6. PD-1 Blockade with the Monoclonal Antibody Pembrolizumab (MK-3475) in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Preliminary Results from a Phase 1b Study (KEYNOTE-013)

Author

Moskowitz, Craig H., primary, Ribrag, Vincent, additional, Michot, Jean-Marie, additional, Martinelli, Giovanni, additional, Zinzani, Pier Luigi, additional, Gutierrez, Martin, additional, De Maeyer, Guadalupe, additional, Jacob, Alexandra G., additional, Giallella, Karen, additional, Weimer Anderson, Jennifer, additional, Derosier, Martha, additional, Wang, Joy, additional, Yang, Zijiang, additional, Rubin, Eric, additional, Rose, Shelonitda, additional, Shipp, Margaret A., additional, and Armand, Philippe, additional

Published
2014
Full Text
View/download PDF

7. Myeloid Derived Suppressor Cells (MDSCs) Regulate Tumor Growth, Immune Response and Regulatory T Cell (Treg) Development in the Multiple Myeloma Bone Marrow Microenvironment

Author

Gorgun, Gullu Topal, primary, Whitehill, Gregory, additional, Anderson, Jennifer Lindsey, additional, Hideshima, Teru, additional, Laubach, Jacob P., additional, Raje, Noopur, additional, Munshi, Nikhil C., additional, Richardson, Paul G., additional, and Anderson, Kenneth C., additional

Published
2012
Full Text
View/download PDF

8. Adaptive Immunotherapy In Multiple Myeloma: Epigenetic Modification and Immunomodulation by Sequential Azacitidine and Lenalidomide to Generate Cancer Testis Antigen Specific Cellular Immune Response

Author

Toor, Amir A, primary, Payne, Kyle, additional, Chung, Harold M, additional, Roberts, Catherine H, additional, Sabo, Roy T, additional, Kmieciak, Maciej, additional, Clark, William, additional, McLaughlin, Christy, additional, Buskey, Angela, additional, Anderson, Jennifer, additional, Manjili, Rose H, additional, Roseff, Susan D., additional, McCarty, John M, additional, and Manjili, Masoud H, additional

Published
2011
Full Text
View/download PDF

11. A Prospective Study of IV Pentamidine for Pneumocystis JiroveciiPneumonia Prophylaxis in Adult Patients with Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplant or Chemotherapy

Author

Anderson, Jennifer, Wirth, Scott, Patel, Pritesh R., Quigley, John G., Oh, Annie L., Mactal-Haaf, Christina, Khan, Irum, Rondelli, Damiano, and Sweiss, Karen

Abstract

Prophylaxis for Pneumocystis jiroveciipneumonia (PJP) is routinely administered to patients undergoing hematopoietic stem cell transplantation (SCT) or intensive chemotherapy. There is continued risk of PJP particularly in SCT recipients when they require prolonged immunosuppression or high dose corticosteroids. Trimethoprim-sulfamethoxazole is the drug of choice but its use is limited by hematologic toxicities. Inhaled pentamidine is an alternative, but frequently causes bronchospasm, needs to be given by a respiratory therapist, and requires use of a private room during administration due to its teratogenicity. Intravenous (IV) pentamidine is FDA approved for PJP treatment, and overcomes these challenges. We conducted the first ever prospective study of IV pentamidine for PJP prophylaxis in adult patients undergoing SCT or intensive chemotherapy.

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results